Status | Study |
Not yet recruiting |
Study Name: Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma Condition: Anemia B-Cell Prolymphocytic Leukemia Fatigue Date: 2017-01-03 Interventions: Drug: Entospletinib Given PO |
Recruiting |
Study Name: Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Condition: Anemia Fatigue Fever Lym Date: 2016-10-26 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station Condition: Urinary Tract Infection Diabetes Mellitus Atrial Fibrillat Date: 2016-07-29 Interventions: Device: Vitaliti |
Not yet recruiting |
Study Name: Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen® Condition: Leucocytosis Date: 2016-04-01 Interventions: Biological: Leucostim® Le |
Recruiting |
Study Name: Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis Condition: Monoclonal B-Cell Lymphocytosis Stage 0 Chronic Lymphocytic Leukemia Date: 2014-12-03 Interventions: Other: Laboratory Biomarker Analysis |
Enrolling by invitation |
Study Name: B-Cell Hematologic Malignancy Vaccination Registry Condition: Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma Date: 2014-11-20 |
Completed |
Study Name: Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion Condition: Leukocytosis Date: 2014-11-18 Interventions: Device: Spectra Optia® Apheresis System White Blood Cell Depletion |
Active, not recruiting |
Study Name: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Condition: Anemia Chronic Lymphocytic Leukemia Fatigue Date: 2014-01-27 Interventions: Drug: Cyclophosphamide Given I |
Recruiting |
Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease Condition: Bone Marrow Failure Syndrome Severe Aplastic Anemia Severe Date: 2013-10-17 Interventions: Biological: CD34 Stem Cell Selection Therapy The CliniMacs (PLUS) Reagent System (Miltenyi CliniMacs CD3 |
Withdrawn |
Study Name: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis Condition: Apoptotic DNA Damage Rheumatoid Arthritis T-cell Lymphocyt Date: 2012-10-24 Interventions: Drug: Group 1 or Orencia treated group |